🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Warsaw
Clinical trial register · Poland

Clinical Trials in Warsaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2681 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2681
Studies in scope
all four open statuses
1400
Recruiting now
open to new participants
514
Lead sponsors
across recruiting studies
Top sites
Warsaw 1297 Krakow 869 Poznan 699 Gdansk 656 Lodz 622
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca94 Merck Sharp & Dohme LLC84 Medical University of Warsaw65 Hoffmann-La Roche61 Janssen Research & Development, LLC44
Site location
Warsaw1297 Krakow869 Poznan699 Gdansk656 Lodz622
All 261 locations
Target enrolment
to

Trials with a site in Warsaw

1297 of 2681 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
DrugALXN2220
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Warsaw, Gdansk, Poznan
2027-11-23
Not yet open
GOAt Milk Formula-based Ladder Versus Cow's Milk Ladder
NCT07795957Food Allergy, Cow's Milk Protein Allergy, Cow's Milk Allergy
Medical University of Warsaw
Not applicable
92
Lodz, Warsaw
2027-01-02
Not yet open
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
NCT07471230Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere
Biocells Medical
Phase 2
120
Warsaw
2026-11-23
Not yet open
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
NCT07222553Immunoglobulin G4-related Disease
DrugInebilizumab
Amgen
Phase 2
15
Warsaw
2026-10-31
Not yet open
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
NCT07830732Haemophilia A
Novo Nordisk A/S
Phase 3
84
Gdansk, Lodz, Poznan, Warsaw
2026-10-09
Not yet open
Remote Monitoring and Optimization of Heart Failure Therapy
NCT07622472Heart Failure
Zoll Medical Corporation
Not applicable
800
Warsaw
2026-10-01
Recruiting
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
NCT07540988Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
466
Gdansk, Poznan, Świdnik, Warsaw
2026-09-14
Not yet open
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
NCT07285798Irritability Associated With Autism Spectrum Disorder
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
176
Poznan, Wroclaw, Warsaw, Gdansk, Szczecin, Katowice, Lublin
2026-09-11
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Bielsko-Biala, Bydgoszcz, Katowice, Krakow, Olsztyn, Poznan, Warsaw, Wałbrzych
2026-09-11
Recruiting
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200Essential Thrombocythemia
DrugINCA033989
Incyte Corporation
Phase 3
426
Gdansk, Katowice, Krakow, Lodz, Lublin, Warsaw, Wałbrzych
2026-09-08
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161Myelofibrosis, Anemia
DrugElritercept
Takeda
Phase 3
324
Poznan, Torun, Warsaw, Chorzów, Katowice, Lodz
2026-09-02
Not yet open
Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation Of Nonspecific Chronic Pain
NCT07273006Non-specific Low Back Pain (NSLBP), Facet Joint Syndrome
Universidad Complutense de Madrid
Phase 4
82
Warsaw
2026-09-01
Not yet open
Routine White Test for Early Detection of Bile Leak in Elective Liver Resection (DELiveR Trial)
NCT07511907Bile Leak, Liver Resection, Hepatectomy
Medical University of Warsaw
Not applicable
270
Warsaw
2026-09-01
Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
NCT07624305Renal Insufficiency, Chronic
DrugsBalcinrenone/dapagliflozin·Dapagliflozin
AstraZeneca
Phase 3
2,800
Olsztyn, Warsaw, Węgrów, Wroclaw, Żywiec
2026-09-01
Not yet open
Autologous Stem Cell Therapy in Patients With Multiple System Atrophy
NCT07465198MSA - Multiple System Atrophy, MSA
Biocells Medical
Phase 2
50
Warsaw
2026-09-01
Not yet open
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
NCT07817875Obesity
DrugTirzepatide
Eli Lilly and Company
Phase 3
150
Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Warszewo, Wroclaw
2026-09
Not yet open
Multi-Food Oral Immunotherapy for Peanut and Tree Nuts
NCT07764159Food Allergies, Food Allergy in Children, Peanut Allergies, Tree Nut Allergies
Medical University of Warsaw
Not applicable
39
Poznan, Krakow, Dziekanów Leśny, Warsaw
2026-09
By invitation
Applications of a Functional Dairy Product in Diet Therapy
NCT07793487Metabolic Syndrome, IBS - Irritable Bowel Syndrome
Warsaw University of Life Sciences
Not applicable
80
Warsaw
2026-09
Recruiting
TCP-600 Supplementation and Performance Response in Professional Football Players
NCT07710547Athletic Performance, Cognitive Fatigue, Exercise Recovery, Football-Specific Performance
Vizja University in Warsaw
Not applicable
65
Krakow, Lodz, Warsaw
2026-09
Recruiting
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465Symptomatic Genetic Dilated Cardiomyopathy (DCM)
DrugDanicamtiv
Kardigan, Inc.
Phase 3
332
Gdansk, Krakow, Lodz, Warsaw
2026-08-26
Not yet open
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
NCT07700979Gastric / Gastroesophageal Junction Adenocarcinoma
DrugsFolfox·Cadonilimab·Nivolumab
Akeso
Phase 3
900
Krakow, Poznan, Warsaw
2026-08-20
Recruiting
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
NCT07686263Schizophrenia
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
472
Warsaw, Bialystok, Poznan
2026-08-20
Recruiting
A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland
NCT07623174Metastatic Colorectal Cancer
Takeda
Observational
110
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Opole, Przemyśl, Bialystok
2026-08-13
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
NCT07770841Overweight, Obesity
DrugSemaglutide
Novo Nordisk A/S
Phase 3
450
Bialystok, Bydgoszcz, Bygdoszcz, Lodz, Poznan, Staszów, Warsaw
2026-08-12
Recruiting
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
NCT07619131Hypercholesterolaemia
DrugsRosuvastatin 1·Rosuvastatin 2
AstraZeneca
Phase 3
600
Częstochowa, Gdynia, Katowice, Lodz, Lublin, Warsaw
2026-08-12
Recruiting
Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation
NCT07792239Atrial Fibrillation (AF), Paroxysmal AF
Xyra, LLC
Phase 2
100
Gdynia, Krakow, Rzeszów, Warsaw
2026-08-06
Recruiting
Imageless Navigation Versus Image-Based Navigation in Robotic-Assisted Total Knee Arthroplasty for Knee Osteoarthritis
NCT07522489Osteoarthritis (OA) of the Knee, Knee Pain Arthritis, Total Knee Arthroplasty (TKA), Robotic Assisted Arthroplasty
Medical University of Warsaw
Not applicable
146
Warsaw
2026-08-06
Recruiting
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
NCT07612267Lactation, Inflammatory Bowel Disease
DrugMirikizumab
Eli Lilly and Company
Phase 4
14
Radom, Warsaw
2026-08-05
Recruiting
Intracardiac Echocardiography-guided Versus Electroanatomical Mapping-guided Pulsed Field Ablation for Paroxysmal Atrial Fibrillation
NCT07772518Paroxysmal Atrial Fibrillation (PAF)
Mitera Hospital
Not applicable
292
Warsaw
2026-08-01
Not yet open
Intraoperative Glycemic Variability and Infectious Complications After Liver Transplantation
NCT07786857Liver Transplantation (LT)
Medical University of Warsaw
Observational
240
Warsaw
2026-08-01
Not yet open
Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservation Technique With and Without Connective Tissue Graft in the Treatment of Periodontal Intraosseous Defects.
NCT07737834Intrabony Periodontal Defect
Medical University of Warsaw
Not applicable
30
Warsaw, Bialystok, Szczecin
2026-08-01
Recruiting
A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure
NCT07353710Atrial Arrhythmia, Intracardiac Echocardiography
Boston Scientific Corporation
Not applicable
200
Warsaw
2026-07-28
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087Systemic Sclerosis
Boehringer Ingelheim
Phase 3
448
Bialystok, Bydgoszcz, Krakow, Poznan, Warsaw
2026-07-27
Recruiting
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
NCT07366034Fibrosing Interstitial Lung Disease
DrugNerandomilast
Boehringer Ingelheim
Phase 3
35
Warsaw
2026-07-21
Recruiting
Efficacy of Platelet-Rich Plasma Added to Hyaluronic Acid in Knee Osteoarthritis
NCT07785401Knee Osteoarthritis, Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA), Osteoarthritis (OA) of the Knee
Implai Sp z o.o
Not applicable
50
Warsaw
2026-07-20
Recruiting
QUality of Sleep Improvement With Evening Topical Therapy for Non-Erosive Gastroesophageal Reflux Disease (The QUIET Trial)
NCT07700342Nocturnal Symptoms of GERD, Sleep Disorders in GERD, GERD (Gastroesophageal Reflux Disease), Non-Erosive Gastro-Esophageal Reflux Disease
Cellmedis
Not applicable
50
Warsaw
2026-07-09
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
NCT07664553Type 2 Diabetes Mellitus
DrugElecoglipron
AstraZeneca
Phase 3
600
Bialystok, Częstochowa, Kielce, Krakow, Lodz, Poznan, Radom, Warsaw
2026-07-08
Recruiting
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
NCT07662213Type 2 Diabetes Mellitus
DrugsElecoglipron·Semaglutide
AstraZeneca
Phase 3
1,200
Bialystok, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
NCT07662109Type 2 Diabetes Mellitus
DrugsElecoglipron·Dapagliflozin
AstraZeneca
Phase 3
2,000
Bialystok, Częstochowa, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
NCT07220252Relapsing Multiple Sclerosis
DrugsUblituximab·Fingolimod
TG Therapeutics, Inc.
Phase 2/3
240
Gdansk, Poznan, Warsaw
2026-07-01
Recruiting
Pridopidine Phase 3 Study in Huntington's Disease
NCT07609108Huntington Disease
DrugPridopidine
Prilenia
Phase 3
400
Krakow, Warsaw
2026-07-01
Recruiting
Body-Focused Mindfulness as an Add-on Intervention in Inpatient Alcohol Use Disorder Treatment (MBI-AUD-PL)
NCT07706660Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Medical University of Warsaw
Not applicable
240
Warsaw
2026-07-01
Not yet open
ESPB Versus Intravenous Lidocaine for Pain After Mastopexy
NCT07687069Breast Hypertrophy
Centre of Postgraduate Medical Education
Not applicable
80
Warsaw
2026-07
Recruiting
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
NCT07665723Active Ulcerative Colitis
DrugsDextromethorphan·Caffeine·Afimkibart·Omeprazole
Hoffmann-La Roche
Phase 1
25
Bydgoszcz, Lodz, Lublin, Nowy Targ, Pabianice, Późna, Warsaw, Wroc?aw
2026-06-29
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Gdansk, Gliwice, Lodz, Opole, Poznan, Szczecin, Warsaw
2026-06-26
Recruiting
Ravulizumab Outcomes in Polish Patients With aHUS
NCT07399730Atypical Hemolytic Uremic Syndrome
DrugRavulizumab
AstraZeneca
Observational
80
Gdansk, Katowice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2026-06-24
Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
NCT07555938Multiple Myeloma
DrugsCevostamab·Elotuzumab·Carfilzomib·Pomalidomide
Hoffmann-La Roche
Phase 3
380
Krakow, Gda?sk, Warsaw, Wroc?aw
2026-06-23
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606B-cell Non Hodgkin Lymphoma
DrugRituximab
Taiho Oncology, Inc.
Phase 1
140
Katowice, Krakow, Skorzewo, Warsaw
2026-06-22
Recruiting
Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer
NCT07669298Rectal Cancer
Medical University of Gdansk
Not applicable
480
Gdansk, Warsaw
2026-06-14
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Bialystok, Krakow, Lodz, Poznan, Rzeszów, Warsaw
2026-06-11
Recruiting
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
NCT07220915Hypogammaglobulinemia, Autoimmune Conditions, Rheumatic Conditions, Infections
DrugPanzyga
Octapharma
Phase 3
360
Warsaw
2026-06-10
Not yet open
Mental Rehearsal in Emergency Cricothyroidotomy Training
NCT07625072Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy
Medical University of Warsaw
Not applicable
60
Warsaw
2026-06-08
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Bydgoszcz, Poznan, Rzeszów, Sopot, Szczecin, Tychy, Warsaw, Wroclaw
2026-06-08
Recruiting
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
NCT06494878Venous Thromboembolism, Postpartum Period, Aspirin, Low Molecular Weight Heparin
DrugsDalteparin·Tinzaparin·Low molecular weight heparin·Enoxaparin
University of Calgary
Phase 3
8,805
Warsaw
2026-06-04
Not yet open
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
NCT07604883PARKINSON DISEASE (Disorder), Atypical Parkinsonism, Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)
International Institute of Molecular and Cell Biology in Warsaw
Observational
200
Warsaw
2026-06-04
Recruiting
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
NCT07024706Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
DrugsAcalabrutinib·Venetoclax
AstraZeneca
Phase 2
80
Bydgoszcz, Krakow, Lodz, Lublin, Warsaw
2026-06-04
Recruiting
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
NCT07620392Rheumatoid Arthritis
DrugAfimkibart
Hoffmann-La Roche
Phase 2
120
Warsaw, Bytom, Elblag, Lublin, Nowa Sól, Wroclaw
2026-06-03
Recruiting
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
NCT07519902Persistent Corneal Epithelial Defect
DrugCenegermin
Dompé Farmaceutici S.p.A
Phase 3
150
Lublin, Warsaw, Katowice
2026-06-02
Not yet open
Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy
NCT07467733Spinocerebellar Ataxia - All Sub-types
DrugIntranasal
Biocells Medical
Phase 1/2
90
Warsaw
2026-06-01
Not yet open
CardioNETPOL National Registry of Carcinoid Heart Disease
NCT07450287Carcinoid Heart Disease, Neuroendocrine Tumors, Carcinoid Syndrome, Valvular Heart Disease Patients
National Institute of Cardiology, Warsaw, Poland
Observational
120
Warsaw
2026-06-01
Recruiting
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07192952Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
DrugFinerenone
Bayer
Phase 3
117
Warsaw, Katowice, Lódz, Wroclaw
2026-06-01
By invitation
The Importance of Mucosal Screening in the Prevention of Oral Cancer.
NCT07682883OPMD, Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer, Oral Potentially Malignant Lesions, Leukoplakia Oral
Medical University of Warsaw
Not applicable
1,383
Warsaw
2026-06-01
Not yet open
Intraoperative Lidocaine or Dexmedetomidine for Postoperative Pain Modulation After Urethral Reconstruction.
NCT07676942Urethral Stricture
Centre of Postgraduate Medical Education
Not applicable
80
Warsaw
2026-06
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT07518186Multiple Myeloma
DrugsJNJ-79635322·Teclistamab
Janssen Research & Development, LLC
Phase 3
700
Bydgoszcz, Gdansk, Katowice, Lublin, Warsaw, Wałbrzych
2026-05-31
Recruiting
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
NCT07470879Colitis, Ulcerative
DrugEtrasimod
Pfizer
Phase 2
24
Warsaw, Katowice
2026-05-28
Recruiting
New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)
NCT07624383GERD (Gastroesophageal Reflux Disease), NERD, Heartburn, Regurgitation, Gastric
Cellmedis
Not applicable
50
Warsaw
2026-05-28
Recruiting
Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
NCT07519057Liver Transplantation, Liver Transplant, Liver Transplant Surgery, End Stage Liver Disease
Medical University of Warsaw
Not applicable
434
Warsaw
2026-05-27
Recruiting
Genetic, Microbiological and Behavioral Factors in Obesity
NCT07650149Obesity & Overweight, Obesity, Genetics
Jan Kochanowski University
Observational
200
Krakow, Warsaw
2026-05-23
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT07422480Myelodysplastic Syndrome, Anemia
DrugsEpoetin Alfa·Elritercept
Takeda
Phase 3
300
Wroclaw, Krakow, Warsaw, Katowice, Skorzewo
2026-05-21
Recruiting
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
NCT07564414Obesity, Type 2 Diabetes
DrugsCagriSema·Semaglutide
Novo Nordisk A/S
Phase 3
2,500
Bialystok, Bygdoszcz, Dębica, Katowice, Krakow, Poznan, Rzeszów, Warsaw
2026-05-21
Recruiting
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
NCT07554495Polyarticular Course Juvenile Idiopathic Arthritis
DrugFilgotinib
Alfasigma S.p.A.
Phase 3
65
Bydgoszcz, Torun, Warsaw
2026-05-21
Recruiting
Functional Limitations, Body Structure and Function Impairments, and Quality of Life in Adults After Surgical Treatment of Adolescent Idiopathic Scoliosis
NCT07559539Adolescence Idiopathic Scoliosis
Józef Piłsudski University of Physical Education
Observational
90
Warsaw
2026-05-16
Recruiting
A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
NCT07547813Hidradenitis Suppurativa
Almirall, S.A.
Phase 2
50
Warsaw
2026-05-13
Recruiting
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
NCT07501702Myasthenia Gravis, Generalized
DrugPovetacicept
Vertex Pharmaceuticals Incorporated
Phase 2
30
Bydgoszcz, Katowice, Poznan, Warsaw
2026-05-13
Recruiting
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
NCT07370649Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection, Virologically Suppressed HIV-1 Infection Receiving Long-Acting Antiretroviral Therapy
DrugCabotegravir
Pomeranian Medical University Szczecin
Observational
250
Szczecin, Bydgoszcz, Gdansk, Warsaw, Wroclaw
2026-05-12
Recruiting
Assessment of LVOT VTI in Healthy Volunteers
NCT07600931Hemodynamic Assessment, Bedside Ultrasonography, Point of Care Ultrasound (POCUS)
Medical University of Warsaw
Observational
30
Warsaw
2026-05-11
Recruiting
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
NCT07438405Thyroid Eye Disease
DrugAMG 732
Amgen
Phase 2
30
Warsaw
2026-05-07
Recruiting
Evaluation of the Effectiveness and Safety of Mesotherapy in the Treatment of Chronic Low Back Pain Syndrome
NCT07675304Chronic Low Back Pain (Non-specific, Uncomplicated)
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Phase EARLY_PHASE1
90
Warsaw
2026-05-06
Recruiting
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT05199688Neuromyelitis Optica Spectrum Disorder, NMOSD
DrugSatralizumab
Hoffmann-La Roche
Phase 3
8
Gda?sk, Warsaw
2026-05-06
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
NCT07545759Irritable Bowel Syndrome, Diarrhea
DrugBrenipatide
Eli Lilly and Company
Phase 2
531
Katowice, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Zamość
2026-05-06
Recruiting
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
NCT07606066Type 2 Diabetes
AstraZeneca
Observational
2,150
Lublin, Krakow, Radom, Bialystok, Częstochowa, Poznan, Warsaw, Lodz
2026-05-06
Recruiting
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571005Obesity, Overweight, Obstructive Sleep Apnoea
DrugNNC0487-0111
Novo Nordisk A/S
Phase 3
300
Wroclaw, Gdansk, Krakow, Poznan, Warsaw
2026-05-05
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571109Obesity, Overweight, Obstructive Sleep Apnoea
DrugNNC0487-0111
Novo Nordisk A/S
Phase 3
300
Wroclaw, Gdansk, Krakow, Poznan, Warsaw
2026-05-05
Recruiting
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
NCT07555483Alpha 1 Antitrypsin Deficiency
Grifols Therapeutics LLC
Phase 3
40
Warsaw
2026-05-05
Recruiting
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
NCT07513376Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
876
Poznan, Warsaw, Lodz, Chęciny
2026-05-04
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
DrugsFPI-2265·Xofigo·Cabazitaxel·Zytiga
AstraZeneca
Phase 3
670
Gdansk, Krakow, Warsaw
2026-05-04
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099Crohn Disease
DrugsLY4395089·Mirikizumab
Eli Lilly and Company
Phase 2
60
Katowice, Krakow, Lublin, Poznan, Siedlce, Szczecin, Warsaw, Zamość
2026-05-04
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
NCT07483073Colitis, Ulcerative, Crohn Disease
DrugsLY4395089·Mirikizumab
Eli Lilly and Company
Phase 2
60
Katowice, Krakow, Lublin, Poznan, Siedlce, Szczecin, Warsaw, Zamość
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Krakow, Warsaw, Gliwice, Katowice
2026-05-03
Recruiting
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
NCT07580716Primary Knee Osteoarthritis
DrugAllocetra
Enlivex Therapeutics Ltd.
Phase 2
270
Bytom, Katowice, Krakow, Poznan, Radom, Swidnica, Warsaw, Wroclaw
2026-05-01
Recruiting
Donidalorsen Treatment in Children With Hereditary Angioedema
NCT07298447Hereditary Angioedema (HAE)
DrugDonidalorsen
Ionis Pharmaceuticals, Inc.
Phase 3
20
Warsaw
2026-04-21
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232Crohn Disease
DrugsRisankizumab·Guselkumab
Janssen Research & Development, LLC
Phase 3
530
Bydgoszcz, Krakow, Rzeszów, Szczecin, Torun, Warsaw
2026-04-21
Recruiting
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
NCT07509307Obesity, Overweight, Osteoarthritis, Knee
DrugNNC0487-0111
Novo Nordisk A/S
Phase 3
400
Bialystok, Bydgoszcz, Krakow, Warsaw
2026-04-20
Recruiting
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
NCT07486960Psoriatic Arthritis
DrugTulisokibart
Merck Sharp & Dohme LLC
Phase 2
140
Bydgoszcz, Torun, Lublin, Warsaw
2026-04-20
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
NCT07409181Systemic Lupus Erythematosus
DrugBI 3000202
Boehringer Ingelheim
Phase 2
405
Bydgoszcz, Krakow, Poznan, Warsaw, Wroclaw
2026-04-20
Recruiting
Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.
NCT07555314Midline Catheter, Lidocaine Infusion, Chronic Pain, Outpatient
Medical University of Warsaw
Observational
500
Warsaw
2026-04-20
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
NCT07415954Diabetes Mellitus, Type 2
DrugsNNC0662-0419·Semaglutide
Novo Nordisk A/S
Phase 2
270
Bialystok, Lublin, Oświęcim, Warsaw, Zabrze
2026-04-17
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
NCT07226843Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma
DrugRituximab
Eli Lilly and Company
Phase 1
460
Katowice, Krakow, Skorzewo, Warsaw
2026-04-17
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugVisugromab
CatalYm GmbH
Phase 2/3
518
Katowice, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2026-04-16
Recruiting
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT07287670Diffuse Cutaneous Systemic Sclerosis
Mediar Therapeutics
Phase 2
85
Bydgoszcz, Nowa Sól, Warsaw
2026-04-16
Rows per page Showing 1–100 of 1297
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-poland/city/warsaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,681 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,297 of those studies with a site in Warsaw.

How many clinical trials are recruiting in Warsaw?

635 of the 1,297 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 47 have not yet opened recruitment, 578 are active but closed to new participants, and 37 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Warsaw), 1,297 studies
PhaseStudiesRecruitingShare
Phase 364325849.6%
Phase 222111017%
Not applicable1408610.8%
Observational125879.6%
Phase 2/349293.8%
Phase 1/247263.6%
Phase 142223.2%
Phase 429162.2%
Phase EARLY_PHASE1110.1%

Most active sponsors

Lead sponsors with the most studies (Warsaw)
Lead sponsorStudiesRecruiting
AstraZeneca9437
Merck Sharp & Dohme LLC8445
Medical University of Warsaw6542
Hoffmann-La Roche6118
Janssen Research & Development, LLC4413
AbbVie3815
Eli Lilly and Company3623
Bristol-Myers Squibb3114
Pfizer3116
Novartis Pharmaceuticals259
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.